law69007 said...
I am with sloan Kettering hospitL with a leading prostate oncologists dr. Howard Scher ... My metastasis surfaCed a month after prostatectomy... I am comming off lupron dec 31 a year after starting it... I was told that taking Avodart might hinder future treatment options and he recommends against it... We are going to cyber knife the lesions on bones with 1-2 treatments to kill the cancer there so it does not return.
I'm taking many supplements recommended by . Dr. Charles "snuffy" myers whom I also consulted in VA. Look him up read his book and seek him out!!!! Please give me input
Dr. Scher is well-known. Why he believes that Avodart (dutasteride) "might hinder future tx options" mystifies me.
Its "label" use is to reduce the size of the prostate by ~50% when treating BPH (Benign Prostatic Hyperplasia).
What we as PCa patients are interested in is this "side effect:" It is a selective inhibitor of both the type 1 and type 2 isoforms of the steroid 5α-reductase, an intracellular enzyme that converts testosterone to dihydrotestosterone (DHT), which is many times as active as testosterone in nourishing PCa cells. I use it, and so do (probably) thousands of our brothers. I'd be very interested to know why Dr. Scher takes that position; what tx options?